Quarterly report [Sections 13 or 15(d)]

Cover
- Cover
Financial Statements
Notes to Financial Statements
Accounting Policies
- Basis of Presentation and Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Asset Acquisition - Narrative (Details)

v3.25.1

Asset Acquisition - Narrative (Details) - USD ($) $ in Thousands				1 Months Ended		3 Months Ended
	Aug. 13, 2024	Mar. 28, 2024	Mar. 27, 2024	Oct. 31, 2024	Apr. 30, 2024	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024
Common stock
Asset Acquisition, Contingent Consideration [Line Items]
Conversion of stock, issuance(in shares)	6,585,314
Series C Preferred Stock
Asset Acquisition, Contingent Consideration [Line Items]
Shares converted (in shares)						200
Almata Transaction And March 2024 Financing
Asset Acquisition, Contingent Consideration [Line Items]
Shares issuable in common stock (in shares)							349
Almata Transaction And March 2024 Financing \| Series C Preferred Stock
Asset Acquisition, Contingent Consideration [Line Items]
Shares issuable in common stock (in shares)			2,412
Shares converted (in shares)			2,063
AlmataBio Transaction
Asset Acquisition, Contingent Consideration [Line Items]
Common stock shares issued (in shares)			171,605
Shares issuable in common stock (in shares)			2,412
Payments to acquire productive assets		$ 7,500			$ 7,500			$ 7,500
AlmataBio Transaction \| Common stock
Asset Acquisition, Contingent Consideration [Line Items]
Conversion of stock, issuance(in shares)			2,062,930
AlmataBio Transaction \| Milestone One
Asset Acquisition, Contingent Consideration [Line Items]
Milestone payment due upon first patient dosed in a Phase 2 and 3 trial		5,000
Payments of merger related costs				$ 5,000
AlmataBio Transaction \| Milestone Two
Asset Acquisition, Contingent Consideration [Line Items]
Milestone payment due upon first patient dosed in a Phase 2 and 3 trial		$ 15,000

- Definition

Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Common Stock Shares

+ References

No definition available.

+ Details

Name:	avtx_AssetAcquisitionEquityInterestIssuedOrIssuableNumberOfCommonStockShares
Namespace Prefix:	avtx_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Convertible Preferred Stock Shares

+ References

No definition available.

+ Details

Name:	avtx_AssetAcquisitionEquityInterestIssuedOrIssuableNumberOfConvertiblePreferredStockShares
Namespace Prefix:	avtx_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaboration Arrangement, Payment

+ References

No definition available.

+ Details

Name:	avtx_CollaborationArrangementPayment
Namespace Prefix:	avtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of liability recognized from contingent consideration in asset acquisition.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

+ Details

Name:	us-gaap_AssetAcquisitionContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Name:	us-gaap_AssetAcquisitionContingentConsiderationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482913/230-10-50-4

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482913/230-10-50-3

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482913/230-10-50-5

+ Details

Name:	us-gaap_ConversionOfStockSharesConverted1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

+ Details

Name:	us-gaap_ConversionOfStockSharesIssued1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480060/805-50-25-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Subparagraph (c)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-13

+ Details

Name:	us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=avtx_AlmataTransactionAndMarch2024FinancingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AssetAcquisitionAxis=avtx_AlmataBioTransactionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	avtx_MilestoneAxis=avtx_MilestoneOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	avtx_MilestoneAxis=avtx_MilestoneTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: